Back to Screener

Financial Services

CME Group Inc(CME)

Live Price

Offline

$226.38

-2.29% today

1Y Change

-9.76%

Window

Jun 25, 2025 β†’ Jun 18, 2026

Market Cap
$103.93B
Revenue Growth
+6.4%
EPS Growth
+15.4%
Dividend Yield
3.9%

Coverage: 247 bars Β· Jun 25, 2025 β†’ Jun 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

CME Group Inc (CME) is a Financial Services stock with a market cap of $103.93B and listed on NASDAQ. The stock last traded around $226.38 and down 9.8% across the available one-year price window (Jun 25, 2025 β†’ Jun 18, 2026). Baseline metrics include revenue growth of +6.4%, EPS growth of +15.4%, a dividend yield of 3.9%. What stands out right now is revenue +6.4%, EPS +15.4%, free cash flow +16.6% with operating margin 65.6% and ROIC 9.4%. The dividend matters to the case here, with a current yield around 3.9%. Valuation already assumes a fairly strong business story at P/E 24.3 and price/sales 15.4. Stock Foundry combines CME price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.

Benchmark Edge

CME vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

CME

β€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

CME Max Drawdown

-24.53%

Trailing 1Y

SPY Max Drawdown

β€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for CME and SPY.

Calendar-year return history is still loading or unavailable.

Financial profile

CME Group Inc (CME)

Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.

FY Revenue

$4.7B

-6.6% YoY

FY Net Income

$2.6B

-2.0% YoY

Free Cash Flow

$2.3B

-23.3% YoY

Revenue Growth

+6.4%

EPS Growth

+15.4%

Gross Margin

86.3%

Net Margin

62.8%

Income statement

USD

Annual
Metric20252024202320222021
Revenue6.5B6.1B5.6B5.0B4.7B
Gross Profit5.6B5.3B4.8B4.3B3.9B
Operating Income4.2B3.9B3.4B3.0B2.6B
EBITDA5.7B5.0B4.7B4.0B3.9B
Net Income4.0B3.5B3.2B2.7B2.6B
EPS (Diluted)β€”β€”β€”β€”β€”

Balance sheet

USD

Point-in-time
Metric20252024202320222021
Cash & Equivalents4.4B2.9B2.9B2.7B2.8B
Total Assets198.5B137.4B129.7B174.2B196.8B
Total Liabilities169.8B111.0B103.0B147.3B169.4B
Shareholder Equity28.7B26.5B26.7B26.9B27.4B
Total Debt3.8B3.4B3.4B3.4B3.4B
Net Debt-666M536M513M718M610M

Cash flow positioning

Latest Full Year

Operating Cash Flow

2.4B

-21.4% YoY

Capital Expenditures

127M

-41.8% YoY

Free Cash Flow

2.3B

-23.3% YoY

Key ratios

  • Gross Margin

    86.3%

  • Operating Margin

    65.6%

  • Net Margin

    62.8%

  • ROE

    15.3%

  • Debt / Equity

    0.13x

Next Step

Turn financials into a decision

Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.